Protective Role of Ashwagandha Leaf Extract and Its Component Withanone on Scopolamine-Induced Changes in the Brain and Brain-Derived Cells
Open Access
- 11 November 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (11), e27265
- https://doi.org/10.1371/journal.pone.0027265
Abstract
Scopolamine is a well-known cholinergic antagonist that causes amnesia in human and animal models. Scopolamine-induced amnesia in rodent models has been widely used to understand the molecular, biochemical, behavioral changes, and to delineate therapeutic targets of memory impairment. Although this has been linked to the decrease in central cholinergic neuronal activity following the blockade of muscarinic receptors, the underlying molecular and cellular mechanism(s) particularly the effect on neuroplasticity remains elusive. In the present study, we have investigated (i) the effects of scopolamine on the molecules involved in neuronal and glial plasticity both in vivo and in vitro and (ii) their recovery by alcoholic extract of Ashwagandha leaves (i-Extract). As a drug model, scopolamine hydrobromide was administered intraperitoneally to mice and its effect on the brain function was determined by molecular analyses. The results showed that the scopolamine caused downregulation of the expression of BDNF and GFAP in dose and time dependent manner, and these effects were markedly attenuated in response to i-Extract treatment. Similar to our observations in animal model system, we found that the scopolamine induced cytotoxicity in IMR32 neuronal and C6 glioma cells. It was associated with downregulation of neuronal cell markers NF-H, MAP2, PSD-95, GAP-43 and glial cell marker GFAP and with upregulation of DNA damage- γH2AX and oxidative stress- ROS markers. Furthermore, these molecules showed recovery when cells were treated with i-Extract or its purified component, withanone. Our study suggested that besides cholinergic blockade, scopolamine-induced memory loss may be associated with oxidative stress and Ashwagandha i-Extract, and withanone may serve as potential preventive and therapeutic agents for neurodegenerative disorders and hence warrant further molecular analyses.Keywords
This publication has 49 references indexed in Scilit:
- Selective Killing of Cancer Cells by Ashwagandha Leaf Extract and Its Component Withanone Involves ROS SignalingPLOS ONE, 2010
- Drug screening to identify suppressors of GFAP expressionHuman Molecular Genetics, 2010
- Ethanol Inhibits Muscarinic Receptor‐Induced Axonal Growth in Rat Hippocampal NeuronsAlcohol: Clinical and Experimental Research, 2009
- Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survivalMolecular Brain, 2009
- Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RETBritish Journal of Pharmacology, 2009
- Premarin improves memory, prevents scopolamine-induced amnesia and increases number of basal forebrain choline acetyltransferase positive cells in middle-aged surgically menopausal ratsHormones and Behavior, 2009
- Cholinergic influence on memory stages: A study on scopolamine amnesic miceIndian Journal of Pharmacology, 2009
- Mouse and rat BDNF gene structure and expression revisitedJournal of Neuroscience Research, 2006
- Scopolamine-induced amnesia can be prevented by heat shock pretreatment in ratsNeuroscience Letters, 2004
- Nuclear factor κb activation by muscarinic receptors in astroglial cells: effect of ethanolNeuroscience, 2003